Evidence map›Paper›PMID 40777321›Full record

ArticlebioRxiv : the preprint server for biology2025

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation.

Mayukha Bathini, Diana Bocaniciu, Fraser D Johnson, Rick C P de Jong, Fengchao Yu, Vincenzo Davide Aloi, Marije C Kuiken, Janniek R Mors, Lisanne Giebel, Julien Champagne and 6 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Mayukha BathiniThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Diana BocaniciuThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Fraser D JohnsonThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Rick C P de JongThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Fengchao YuDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.ORCID 0000-0002-7695-3698
Vincenzo Davide AloiThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Marije C KuikenThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Janniek R MorsThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Lisanne GiebelThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Julien ChampagneThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Onno BleijerveldThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Reuven AgamiThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Krijn K DijkstraThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Daniela S ThommenThe Netherlands Cancer Institute, Amsterdam, the Netherlands.
Alexey I NesvizhskiiDepartment of Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Rik G H LindeboomThe Netherlands Cancer Institute, Amsterdam, the Netherlands.ORCID 0000-0002-3660-504X

Funding

Michigan Center for Translational Cancer Proteogenomics-Diversity SupplementU24CA271037 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Saravana Mohan Dhanasekaran, Alexey I Nesvizhskii · 2022 to 2026
$4.4M
NCI NIH HHS U24 CA271037
6 · The paper itself

Abstract

Profiling antigens presented on MHC class I molecules on the cell surface is essential to identify candidate antigens for targeted and personalized immunotherapies. However, mass spectrometry-based immunopeptidomics has traditionally been limited by high input requirements, extensive sample manipulation, and expensive reagents. To overcome these challenges, we developed MHC1-TIP: a scalable, single-tube and cost-effective workflow to enable robust MHC-I ligandome recovery from cell lines, patient-derived organoids, and sub-milligram amounts of clinical tissues. Moreover, MHC1-TIP also preserves compatibility with additional omics profiling technologies and we demonstrate its capacity for quantitative and multimodal profiling of the proteome and immunopeptidome from the same sample to enable integrated analyses of protein expression and antigen presentation. Application of MHC1-TIP to primary renal cell carcinoma fragments revealed extensive intratumoral heterogeneity in antigen presentation that was poorly correlated with source protein expression. MHC1-TIP represents a broadly applicable and sensitive approach for low-input, multimodal immunopeptidomics with clinical and translational relevance.

Indexed as

HeterogeneityImmunopeptidomicsMulti-omics ProfilingProteomics

Identifiers

PMID40777321
PMCPMC12330465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.